Botanical species · safety record

Cyclamen purpurascens

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Cyclamen purpurascens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cyclamen purpurascens Mill.

7Constituent measurements

1Safety records

4Cited sources

3Licensed products (Canada)

Also recorded as

Cyclamen europaeum L.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Cyclamen purpurascens as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Fresh underground parts
Rhizome(s)
Root

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cinnamaldehyde	Flower	Fresh	1.2 Percent	GC-MS	Resolve DOI
Cyclamine	Roots and other underground parts used as staple food	Solvent extraction	16 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Cyclamine	Bulb / clove	Sap	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Methyl benzoate	Flower	Fresh	0.3 Percent	GC-MS	Resolve DOI
Myrcene	Flower	Fresh	0.3 Percent	GC-MS	Resolve DOI
Pentacyclic triterpene saponins	Bulb / clove	Sap	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Saponins	Unspecified	—	—	Unspecified	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Not reported	—	Unspecified	—	Rat (as animal)	Acute toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Ishizaka, H., Yamada, H., Sasaki, K. Volatile compounds in the flowers of Cyclamen persicum, C-purpurascens and their hybrids . Scientia horticulturae, 2002, vol. 94, no. 1-2, p. 125-135. DOI
Vogel, Guenther., Marek, Marie Luise. Pharmacology of some saponins. Arneimittel-forsch., 1962, vol. 12, p. 815-25.
REZNICEK, G., JURENITSCH, J., ROBIEN, W., KUBELKA, W. SAPONINS IN CYCLAMEN SPECIES - CONFIGURATION OF CYCLAMIRETIN-C AND STRUCTURE OF ISOCYCLAMIN . Phytochemistry, 1989, vol. 28, no. 3, p. 825-828. DOI
Winder, O., Friedrich, C., Jumbam, N. D., Griengl, H., Kartnig, T. Cyclamin, a new Molluscicide from the tubers of Cyclamen purpurascens Mill. tested against the snail Biomphalaria glabrata (Say) . Annales de limnologie-international journal of limnology, 1995, vol. 31, no. 4, p. 229-232. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature